Cancer regression in patients after transfer of genetically engineered lymphocytes. Article

authors

  • Morgan, RA
  • Dudley, ME
  • Wunderlich, JR
  • Hughes, Marybeth S.
  • Yang, JC
  • Sherry, RM
  • Royal, RE
  • Topalian, SL
  • Kammula, US
  • Restifo, NP
  • Zheng, Z
  • Nahvi, A
  • de Vries, CR
  • Rogers-Freezer, LJ
  • Mavroukakis, SA
  • Rosenberg, SA

publication date

  • 2006

published in

PubMed Central ID

  • pmc2267026

start page

  • 126

end page

  • 9

volume

  • 314

issue

  • 5796